...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >EFFECT OF TAMSULOSIN A SELECTIVE α1-ANTAGONIST ON GLUCOSE HOMEOSTASIS IN RATS
【24h】

EFFECT OF TAMSULOSIN A SELECTIVE α1-ANTAGONIST ON GLUCOSE HOMEOSTASIS IN RATS

机译:牛磺酸糖蛋白选择性α1-拮抗剂在大鼠葡萄糖稳态中的作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective : To assess the effect of tamsulosin (α 1 -antagonist) on blood sugar and adrenaline levels in rats. Methods : Wistar rats were divided in to four groups (n=6), Group-I (Normal control) administered normal saline, Group-II, Group-III &Group-IV induced diabetes by administering Streptozotocin IV 50 mg/kg. Group III and Group-IV were administered Tamsulosin 1mg/kg and Glimepiride 10μg/kg respectively for twenty one days. Serum insulin, adrenaline and blood glucose were estimated at before and after drug treatment. Results : Adrenaline and insulin levels were increased significantly (p<0.005) in Diabetic control and Tamsulosin treated diabetic rats compared to Normal control rats. Blood glucose levelsincreased significantly (p<0.005) in Tamsulosin treated diabetic rats compared to Diabetic control rats. All the three parameters are compared at the end of drug treatment. Conclusion: Several studies interpreted a potential role of the α-receptor in glucose metabolism. Inhibition of the α1-receptor pathway can lead to a decreased glucose uptake, and hence an increased plasma glucose concentration. Several studies in one or the other way indicating the correlation between diabetes and BPH and probably in such condition tamsulosin a α1 antagonist is the drug of choice along with oral hypoglycemic agents. Literature survey also shows that there is increase in the blood glucose levels during the use of tamsulosin which impacts blood sugar levels especially in diabetic state. T.h.is study shows increase in blood glucose levels with the use of tamsulosin is making further complications in diabetic patients. This adverse drug reaction and the proposed mechanism need to be proven further. Keywords: α 1 -antagonist, Wistar rats, Streptozotocin.
机译:目的:评价坦索罗辛(α1拮抗剂)对大鼠血糖和肾上腺素水平的影响。方法:Wistar大鼠分为四组(n = 6),第一组(正常对照组)给予生理盐水,第二组,第三组和第四组IV诱导的糖尿病,分别以50 mg / kg的剂量施用链脲佐菌素。 III组和IV组分别服用坦索罗辛1mg / kg和格列美脲10μg/ kg,持续21天。在药物治疗之前和之后估计血清胰岛素,肾上腺素和血糖。结果:与正常对照组相比,糖尿病对照组和坦索罗辛治疗的糖尿病大鼠的肾上腺素和胰岛素水平显着增加(p <0.005)。与糖尿病对照大鼠相比,坦索罗辛治疗的糖尿病大鼠血糖水平显着增加(p <0.005)。在药物治疗结束时比较所有三个参数。结论:一些研究解释了α受体在葡萄糖代谢中的潜在作用。 α1-受体途径的抑制可导致葡萄糖摄取减少,因此血浆葡萄糖浓度增加。一种或另一种方式的多项研究表明,糖尿病与BPH之间存在相关性,在这种情况下坦索罗辛可能与α1拮抗剂一起是口服降糖药的首选药物。文献调查还显示,使用坦索罗辛期间血糖水平升高,这会影响血糖水平,尤其是在糖尿病状态下。 T.h.is研究表明,坦索罗辛的使用使血糖水平升高,使糖尿病患者进一步并发症。这种药物不良反应和拟议的机制需要进一步证明。关键词:α1-拮抗剂,Wistar大鼠,链脲佐菌素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号